Wednesday, December 16, 2009

Facet Bio cuts shareholder deal as Biogen Idec promises proxy fight - Bizjournals.com


Bizjournals.com

Facet Bio cuts shareholder deal as Biogen Idec promises proxy fight
Bizjournals.com
Facet shares closed down 31 cents, to $16.75, and were down 8 cents in after-hours trading Tuesday. Biogen shares, at $49.43, were unchanged in after-hours ...

and more »

No comments:

Post a Comment